Revelation Biosciences, Inc. (REVB) Financials

REVB Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 14.2 million 5.4 million
2023-06-30 16.0 million 4.6 million
2023-03-31 18.1 million 8.1 million
2022-12-31 5.5 million 4.5 million

REVB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.7 million 32096
2023-06-30 -2.0 million 59435
2023-03-31 -1.6 million 32095
2022-12-31 -947467 32361

REVB Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 -2.6 million
2023-06-30 -1.4 million
2023-03-31 6.2 million
2022-12-31 -1.2 million

REVB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 14.0 million - -
2023-06-30 15.7 million - -
2023-03-31 17.7 million - -
2022-12-31 5.3 million - -

REVB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 6.3 million
2023-06-30 5.8 million
2023-03-31 3.1 million
2022-12-31 715713

REVB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.7 million 1.1 million -
2023-06-30 - 909278 1.0 million -
2023-03-31 - 525273 1.1 million -
2022-12-31 - 339971 878356 -

REVB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 6262
2023-06-30 - 6262
2023-03-31 - 6263
2022-12-31 - 6262

REVB

Price: $2.37

52 week price:
1.83
49.80

Earnings Per Share: -0.53 USD

P/E Ratio: -1.19

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 562000

Market Capitalization: 3.4 million

Links: